Skip to main content
Top
Published in: Abdominal Radiology 4/2013

01-08-2013

Intrahepatic cholangiocarcinoma: relationship between tumor imaging enhancement by measuring attenuation and clinicopathologic characteristics

Authors: Atsushi Nanashima, Takafumi Abo, Goushi Murakami, Aya Matsumoto, Kazuo Tou, Hiroaki Takeshita, Masaki Kunizaki, Shigekazu Hidaka, Ichiro Sakamoto, Hideyuki Hayashi, Toru Fukuda, Takashi Kudo, Takeshi Nagayasu

Published in: Abdominal Radiology | Issue 4/2013

Login to get access

Abstract

Purpose

Arterial enhancement of intrahepatic cholangiocarcinoma (ICC) has been noted. To precisely identify the characteristics of tumor enhancement patterns, we examined the relationship between CT attenuation in the tumor and clinicopathological parameters or prognosis.

Methods

Subjects were 42 ICC patients who had undergone hepatectomy. microvessel density (MVD) determined by CD34 staining was compared with imaging. Attenuation was calculated in images from multidetector CT of tumor and non-tumorous regions. Enhancement patterns were divided into two groups: arterial enhancement with higher attenuation (>16 HU; Hyper group, n = 12); and arterial enhancement with lower attenuation (Hypo group, n = 30).

Results

Univariate analysis identified high tumor marker level, increased size, less-differentiation, incomplete resection, increased bleeding, and lower MVD as significantly associated with poor survival (p < 0.05). Increased attenuation throughout the whole ICC correlated significantly with radiological findings and MVD. Concomitant hepatitis, well-differentiation, and smaller tumor were more significantly frequent in the Hyper group than in the Hypo group (p < 0.05). Postoperative early recurrence was significantly less frequent in the Hyper group, and overall survival was significantly better in the Hyper group (p < 0.05).

Conclusions

Increased CT attenuation correlated with ICC tumor vascularity. Increased tumor enhancement in the arterial phase was associated with chronic hepatitis, lower malignancy, and better survival.
Literature
1.
go back to reference Su CH, Tsay SH, Wu CC, et al. (1996) Factors influencing postoperative morbidity, mortality, and survival after resection for hilar cholangiocarcinoma. Ann Surg 223:384–394PubMedCrossRef Su CH, Tsay SH, Wu CC, et al. (1996) Factors influencing postoperative morbidity, mortality, and survival after resection for hilar cholangiocarcinoma. Ann Surg 223:384–394PubMedCrossRef
2.
go back to reference Isa T, Kusano T, Shimoji H, et al. (2001) Predictive factors for long-term survival in patients with intrahepatic cholangiocarcinoma. Am J Surg 181:507–511PubMedCrossRef Isa T, Kusano T, Shimoji H, et al. (2001) Predictive factors for long-term survival in patients with intrahepatic cholangiocarcinoma. Am J Surg 181:507–511PubMedCrossRef
3.
go back to reference Kawarada Y, Yamagiwa K, Das BC (2002) Analysis of the relationships between clinicopathologic factors and survival time in intrahepatic cholangiocarcinoma. Am J Surg 183:679–685PubMedCrossRef Kawarada Y, Yamagiwa K, Das BC (2002) Analysis of the relationships between clinicopathologic factors and survival time in intrahepatic cholangiocarcinoma. Am J Surg 183:679–685PubMedCrossRef
4.
go back to reference Kozaka K, Sasaki M, Fujii T, et al. (2007) A subgroup of intrahepatic cholangiocarcinoma with an infiltrating replacement growth pattern and a resemblance to reactive proliferating bile ductules: ‘bile ductular carcinoma’. Histopathology 51:390–400PubMedCrossRef Kozaka K, Sasaki M, Fujii T, et al. (2007) A subgroup of intrahepatic cholangiocarcinoma with an infiltrating replacement growth pattern and a resemblance to reactive proliferating bile ductules: ‘bile ductular carcinoma’. Histopathology 51:390–400PubMedCrossRef
5.
go back to reference Roskams T (2006) Liver stem cells and their implication in hepatocellular and cholangiocarcinoma. Oncogene 25:3818–3822PubMedCrossRef Roskams T (2006) Liver stem cells and their implication in hepatocellular and cholangiocarcinoma. Oncogene 25:3818–3822PubMedCrossRef
6.
go back to reference Sempoux C, Jibara G, Ward SC, et al. (2011) Intrahepatic cholangiocarcinoma: new insights in pathology. Semin Liver Dis 31:49–60PubMedCrossRef Sempoux C, Jibara G, Ward SC, et al. (2011) Intrahepatic cholangiocarcinoma: new insights in pathology. Semin Liver Dis 31:49–60PubMedCrossRef
7.
go back to reference de Martel C, Plummer M, Franceschi S (2010) Cholangiocarcinoma: descriptive epidemiology and risk factors. Gastroenterol Clin Biol 34:173–180PubMedCrossRef de Martel C, Plummer M, Franceschi S (2010) Cholangiocarcinoma: descriptive epidemiology and risk factors. Gastroenterol Clin Biol 34:173–180PubMedCrossRef
8.
go back to reference Khan SA, Davidson BR, Goldin R, et al. (2002) Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document. Gut 51:1–9CrossRef Khan SA, Davidson BR, Goldin R, et al. (2002) Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document. Gut 51:1–9CrossRef
9.
go back to reference Sano T, Kamiya J, Nagino M, et al. (1999) Macroscopic classification and preoperative diagnosis of intrahepatic cholangiocarcinoma in Japan. J Hepatobiliary Pancreat Surg 6:101–107PubMedCrossRef Sano T, Kamiya J, Nagino M, et al. (1999) Macroscopic classification and preoperative diagnosis of intrahepatic cholangiocarcinoma in Japan. J Hepatobiliary Pancreat Surg 6:101–107PubMedCrossRef
10.
go back to reference Hirohashi K, Uenishi T, Kubo S, et al. (2002) Macroscopic types of intrahepatic cholangiocarcinoma: clinicopathologic features and surgical outcomes. Hepatogastroenterology 49:326–329PubMed Hirohashi K, Uenishi T, Kubo S, et al. (2002) Macroscopic types of intrahepatic cholangiocarcinoma: clinicopathologic features and surgical outcomes. Hepatogastroenterology 49:326–329PubMed
11.
go back to reference Suzuki S, Sakaguchi T, Yokoi Y, et al. (2002) Clinicopathological prognostic factors and impact of surgical treatment of mass-forming intrahepatic cholangiocarcinoma. World J Surg 26:687–693PubMedCrossRef Suzuki S, Sakaguchi T, Yokoi Y, et al. (2002) Clinicopathological prognostic factors and impact of surgical treatment of mass-forming intrahepatic cholangiocarcinoma. World J Surg 26:687–693PubMedCrossRef
12.
go back to reference Ohtsuka M, Ito H, Kimura F, et al. (2002) Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival. Br J Surg 89:1525–1531PubMedCrossRef Ohtsuka M, Ito H, Kimura F, et al. (2002) Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival. Br J Surg 89:1525–1531PubMedCrossRef
13.
go back to reference Thelen A, Scholz A, Weichert W, et al. (2010) Tumor-associated angiogenesis and lymphangiogenesis correlate with progression of intrahepaticcholangiocarcinoma. Am J Gastroenterol 105:1123–1132PubMedCrossRef Thelen A, Scholz A, Weichert W, et al. (2010) Tumor-associated angiogenesis and lymphangiogenesis correlate with progression of intrahepaticcholangiocarcinoma. Am J Gastroenterol 105:1123–1132PubMedCrossRef
14.
go back to reference Miura F, Okazumi S, Takayama W, et al. (2004) Hemodynamics of intrahepatic cholangiocarcinoma: evaluation with single-level dynamic CT during hepatic arteriography. Abdom Imaging 29:467–471PubMedCrossRef Miura F, Okazumi S, Takayama W, et al. (2004) Hemodynamics of intrahepatic cholangiocarcinoma: evaluation with single-level dynamic CT during hepatic arteriography. Abdom Imaging 29:467–471PubMedCrossRef
15.
go back to reference Kim JE, Kim SH, Lee SJ, Rhim H (2011) Hypervascular hepatocellular carcinoma 1 cm or smaller in patients with chronic liver disease: characterization with gadoxetic acid-enhanced MRI that includes diffusion-weighted imaging. AJR Am J Roentgenol 196:W758–W765PubMedCrossRef Kim JE, Kim SH, Lee SJ, Rhim H (2011) Hypervascular hepatocellular carcinoma 1 cm or smaller in patients with chronic liver disease: characterization with gadoxetic acid-enhanced MRI that includes diffusion-weighted imaging. AJR Am J Roentgenol 196:W758–W765PubMedCrossRef
16.
go back to reference Nanashima A, Sumida Y, Abo T, et al. (2008) Relationship between pattern of tumor enhancement and clinicopathologic characteristics in intrahepatic cholangiocarcinoma. J Surg Oncol 98:535–539PubMedCrossRef Nanashima A, Sumida Y, Abo T, et al. (2008) Relationship between pattern of tumor enhancement and clinicopathologic characteristics in intrahepatic cholangiocarcinoma. J Surg Oncol 98:535–539PubMedCrossRef
17.
go back to reference Nanashima A, Shibata K, Nakayama T, et al. (2009) Relationship between microvessel count and postoperative survival in patients with intrahepaticcholangiocarcinoma. Ann Surg Oncol 16:2123–2129PubMedCrossRef Nanashima A, Shibata K, Nakayama T, et al. (2009) Relationship between microvessel count and postoperative survival in patients with intrahepaticcholangiocarcinoma. Ann Surg Oncol 16:2123–2129PubMedCrossRef
18.
go back to reference Nanashima A, Yoshinaga M, Yamaguchi H, et al. (2003) An immunohistochemical study of tumor vascularity and proliferation activity in cholangiocellular carcinoma: relationship to clinicopathological factors and prognosis after hepatic resection. Acta Med Nagasaki 48:23–27 Nanashima A, Yoshinaga M, Yamaguchi H, et al. (2003) An immunohistochemical study of tumor vascularity and proliferation activity in cholangiocellular carcinoma: relationship to clinicopathological factors and prognosis after hepatic resection. Acta Med Nagasaki 48:23–27
19.
21.
go back to reference Fukukura Y, Hamanoue M, Fujiyoshi F, et al. (2000) Cholangiolocellular carcinoma of the liver: CT and MR findings. J Comput Assist Tomogr 24:809–812PubMedCrossRef Fukukura Y, Hamanoue M, Fujiyoshi F, et al. (2000) Cholangiolocellular carcinoma of the liver: CT and MR findings. J Comput Assist Tomogr 24:809–812PubMedCrossRef
22.
go back to reference Jung AY, Lee JM, Choi SH, et al. (2006) CT features of an intraductal polypoid mass: differentiation between hepatocellular carcinoma with bile duct tumor invasion and intraductal papillary cholangiocarcinoma. J Comput Assist Tomogr 30:173–181PubMedCrossRef Jung AY, Lee JM, Choi SH, et al. (2006) CT features of an intraductal polypoid mass: differentiation between hepatocellular carcinoma with bile duct tumor invasion and intraductal papillary cholangiocarcinoma. J Comput Assist Tomogr 30:173–181PubMedCrossRef
23.
go back to reference Song SJ, Lee JM, Kim YJ, et al. (2007) Differentiation of intraductal papillary mucinous neoplasms from other pancreatic cystic masses: comparison of multirow-detector CT and MR imaging using ROC analysis. J Magn Reson Imaging 26:86–93PubMedCrossRef Song SJ, Lee JM, Kim YJ, et al. (2007) Differentiation of intraductal papillary mucinous neoplasms from other pancreatic cystic masses: comparison of multirow-detector CT and MR imaging using ROC analysis. J Magn Reson Imaging 26:86–93PubMedCrossRef
24.
go back to reference Nakanuma Y, Xu J, Harada K, et al. (2011) Pathological spectrum of intrahepatic cholangiocarcinoma arising in non-biliary chronic advanced liver diseases. Pathol Int 61:298–305PubMedCrossRef Nakanuma Y, Xu J, Harada K, et al. (2011) Pathological spectrum of intrahepatic cholangiocarcinoma arising in non-biliary chronic advanced liver diseases. Pathol Int 61:298–305PubMedCrossRef
25.
go back to reference Xu J, Igarashi S, Sasaki M, et al. (2012) Intrahepatic cholangiocarcinomas in cirrhosis are hypervascular in comparison with those in normal livers. Liver Int 32:1156–1164PubMedCrossRef Xu J, Igarashi S, Sasaki M, et al. (2012) Intrahepatic cholangiocarcinomas in cirrhosis are hypervascular in comparison with those in normal livers. Liver Int 32:1156–1164PubMedCrossRef
26.
go back to reference Xu J, Sasaki M, Harada K, et al. (2011) Intrahepatic cholangiocarcinoma arising in chronic advanced liver disease and the cholangiocarcinomatous component of hepatocellular cholangiocarcinoma share common phenotypes and cholangiocarcinogenesis. Histopathology 59:1090–1099PubMedCrossRef Xu J, Sasaki M, Harada K, et al. (2011) Intrahepatic cholangiocarcinoma arising in chronic advanced liver disease and the cholangiocarcinomatous component of hepatocellular cholangiocarcinoma share common phenotypes and cholangiocarcinogenesis. Histopathology 59:1090–1099PubMedCrossRef
27.
go back to reference Jung EM, Ross CJ, Rennert J, et al. (2010) Characterization of microvascularization of liver tumor lesions with high resolution linear ultrasound and contrast enhanced ultrasound (CEUS) during surgery: first results. Clin Hemorheol Microcirc 46:89–99PubMed Jung EM, Ross CJ, Rennert J, et al. (2010) Characterization of microvascularization of liver tumor lesions with high resolution linear ultrasound and contrast enhanced ultrasound (CEUS) during surgery: first results. Clin Hemorheol Microcirc 46:89–99PubMed
28.
go back to reference Nanashima A, Yamaguchi H, Shibasaki S, et al. (2006) Relationship between CT volumetry and functional liver volume using technetium-99 m galactosyl serum albumin scintigraphy in patients undergoing preoperative portal vein embolization before major hepatectomy: a preliminary study. Dig Dis Sci 51:1190–1195PubMedCrossRef Nanashima A, Yamaguchi H, Shibasaki S, et al. (2006) Relationship between CT volumetry and functional liver volume using technetium-99 m galactosyl serum albumin scintigraphy in patients undergoing preoperative portal vein embolization before major hepatectomy: a preliminary study. Dig Dis Sci 51:1190–1195PubMedCrossRef
29.
go back to reference Liver Cancer Study group of Japan (2003). In: Makuuchi M, (ed). The general rules for the clinical and pathological study of primary liver cancer, 2nd English edition. Tokyo: Kanehara Co., pp 6–28. Liver Cancer Study group of Japan (2003). In: Makuuchi M, (ed). The general rules for the clinical and pathological study of primary liver cancer, 2nd English edition. Tokyo: Kanehara Co., pp 6–28.
30.
go back to reference Park HS, Lee JM, Choi JY, et al. (2008) Preoperative evaluation of bile duct cancer: MRI combined with MR cholangiopancreatography versus MDCT with direct cholangiography. AJR Am J Roentgenol 190:396–405PubMedCrossRef Park HS, Lee JM, Choi JY, et al. (2008) Preoperative evaluation of bile duct cancer: MRI combined with MR cholangiopancreatography versus MDCT with direct cholangiography. AJR Am J Roentgenol 190:396–405PubMedCrossRef
31.
go back to reference Chamberlain RS, Blumgart LH (1999) Hilar cholangiocarcinoma: a review and commentary. Ann Surg Oncol 7:55–66CrossRef Chamberlain RS, Blumgart LH (1999) Hilar cholangiocarcinoma: a review and commentary. Ann Surg Oncol 7:55–66CrossRef
32.
go back to reference Valls C, Gumà A, Puig I, et al. (2000) Intrahepatic peripheral cholangiocarcinoma: CT evaluation. Abdom Imaging 25:490–496PubMedCrossRef Valls C, Gumà A, Puig I, et al. (2000) Intrahepatic peripheral cholangiocarcinoma: CT evaluation. Abdom Imaging 25:490–496PubMedCrossRef
33.
go back to reference Sano T, Kamiya J, Nagino M, et al. (1999) Macroscopic classification and preoperative diagnosis of intrahepatic cholangiocarcinoma in Japan. J Hepatobiliary Pancreat Surg 6:101–107PubMedCrossRef Sano T, Kamiya J, Nagino M, et al. (1999) Macroscopic classification and preoperative diagnosis of intrahepatic cholangiocarcinoma in Japan. J Hepatobiliary Pancreat Surg 6:101–107PubMedCrossRef
34.
go back to reference Sanada Y, Yoshida K, Itoh H (2007) Comparison of CT enhancement patterns and histologic features in hepatocellular carcinoma up to 2 cm: assessment of malignant potential with claudin-10 immunohistochemistry. Oncol Rep 17:1177–1182PubMed Sanada Y, Yoshida K, Itoh H (2007) Comparison of CT enhancement patterns and histologic features in hepatocellular carcinoma up to 2 cm: assessment of malignant potential with claudin-10 immunohistochemistry. Oncol Rep 17:1177–1182PubMed
35.
go back to reference Kim NR, Lee JM, Kim SH, et al. (2008) Enhancement characteristics of cholangiocarcinomas on mutiphasic helical CT: emphasis on morphologic subtypes. Clin Imaging 32:114–120PubMedCrossRef Kim NR, Lee JM, Kim SH, et al. (2008) Enhancement characteristics of cholangiocarcinomas on mutiphasic helical CT: emphasis on morphologic subtypes. Clin Imaging 32:114–120PubMedCrossRef
36.
go back to reference Kim SJ, Lee JM, Han JK, et al. (2007) Peripheral mass-forming cholangiocarcinoma in cirrhotic liver. AJR Am J Roentgenol 189:1428–1434PubMedCrossRef Kim SJ, Lee JM, Han JK, et al. (2007) Peripheral mass-forming cholangiocarcinoma in cirrhotic liver. AJR Am J Roentgenol 189:1428–1434PubMedCrossRef
37.
go back to reference Hai S, Kubo S, Yamamoto S, et al. (2005) Clinicopathologic characteristics of hepatitis C virus-associated intrahepatic cholangiocarcinoma. Dig Surg 22:432–439PubMedCrossRef Hai S, Kubo S, Yamamoto S, et al. (2005) Clinicopathologic characteristics of hepatitis C virus-associated intrahepatic cholangiocarcinoma. Dig Surg 22:432–439PubMedCrossRef
38.
go back to reference Polizos A, Kelekis N, Sinani C, et al. (2003) Advanced intrahepatic cholangiocarcinoma in hepatitis C virus-related decompensated cirrhosis: case report and review of the literature. Eur J Gastroenterol Hepatol 15:331–334PubMedCrossRef Polizos A, Kelekis N, Sinani C, et al. (2003) Advanced intrahepatic cholangiocarcinoma in hepatitis C virus-related decompensated cirrhosis: case report and review of the literature. Eur J Gastroenterol Hepatol 15:331–334PubMedCrossRef
39.
go back to reference Perumal V, Wang J, Thuluvath P, et al. (2006) Hepatitis C and hepatitis B nucleic acids are present in intrahepatic cholangiocarcinomas from the United States. Hum Pathol 37:1211–1216PubMedCrossRef Perumal V, Wang J, Thuluvath P, et al. (2006) Hepatitis C and hepatitis B nucleic acids are present in intrahepatic cholangiocarcinomas from the United States. Hum Pathol 37:1211–1216PubMedCrossRef
40.
go back to reference Alison MR (2005) Liver stem cells: implications for hepatocarcinogenesis. Stem Cell Rev 1:253–260PubMedCrossRef Alison MR (2005) Liver stem cells: implications for hepatocarcinogenesis. Stem Cell Rev 1:253–260PubMedCrossRef
41.
go back to reference Acalovschi M (2004) Cholangiocarcinoma: risk factors, diagnosis and management. Rom J Intern Med 42:41–58PubMed Acalovschi M (2004) Cholangiocarcinoma: risk factors, diagnosis and management. Rom J Intern Med 42:41–58PubMed
42.
go back to reference Yamamoto M, Ariizumi S, Otsubo T, et al. (2004) Intrahepatic cholangiocarcinoma diagnosed preoperatively as hepatocellular carcinoma. J Surg Oncol 87:80–83PubMedCrossRef Yamamoto M, Ariizumi S, Otsubo T, et al. (2004) Intrahepatic cholangiocarcinoma diagnosed preoperatively as hepatocellular carcinoma. J Surg Oncol 87:80–83PubMedCrossRef
43.
go back to reference Asayama Y, Yoshimitsu K, Irie H, et al. (2006) Delayed-phase dynamic CT enhancement as a prognostic factor for mass-forming intrahepatic cholangiocarcinoma. Radiology 238:150–155PubMedCrossRef Asayama Y, Yoshimitsu K, Irie H, et al. (2006) Delayed-phase dynamic CT enhancement as a prognostic factor for mass-forming intrahepatic cholangiocarcinoma. Radiology 238:150–155PubMedCrossRef
44.
go back to reference Shirabe K, Shimada M, Tsujita E, et al. (2004) Prognostic factors in node-negative intrahepatic cholangiocarcinoma with special reference to angiogenesis. Am J Surg 187:538–542PubMedCrossRef Shirabe K, Shimada M, Tsujita E, et al. (2004) Prognostic factors in node-negative intrahepatic cholangiocarcinoma with special reference to angiogenesis. Am J Surg 187:538–542PubMedCrossRef
45.
go back to reference Leelawat K, Leelawat S, Ratanachu-Ek T, et al. (2006) Circulating hTERT mRNA as a tumor marker in cholangiocarcinoma patients. World J Gastroenterol 12:4195–4198PubMed Leelawat K, Leelawat S, Ratanachu-Ek T, et al. (2006) Circulating hTERT mRNA as a tumor marker in cholangiocarcinoma patients. World J Gastroenterol 12:4195–4198PubMed
Metadata
Title
Intrahepatic cholangiocarcinoma: relationship between tumor imaging enhancement by measuring attenuation and clinicopathologic characteristics
Authors
Atsushi Nanashima
Takafumi Abo
Goushi Murakami
Aya Matsumoto
Kazuo Tou
Hiroaki Takeshita
Masaki Kunizaki
Shigekazu Hidaka
Ichiro Sakamoto
Hideyuki Hayashi
Toru Fukuda
Takashi Kudo
Takeshi Nagayasu
Publication date
01-08-2013
Publisher
Springer US
Published in
Abdominal Radiology / Issue 4/2013
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-012-9974-3

Other articles of this Issue 4/2013

Abdominal Radiology 4/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.